Reduced antibody response to streptavidin through site-directed mutagenesis

Protein Science : a Publication of the Protein Society
D L MeyerS S Graves

Abstract

Streptavidin provides an effective receptor for biotinylated tumoricidal molecules, including radionuclides, when conjugated to an antitumor antibody and administered systemically. Ideally, one would like to administer this bacterial protein to patients repeatedly, so as to maximize the antitumor effect without eliciting an immune response. Therefore, we attempted to reduce the antigenicity of streptavidin by mutating surface residues capable of forming high energy ionic or hydrophobic interactions. A crystallographic image of streptavidin was examined to identify residues with solvent-exposed side chains and residues critical to streptavidin's structure or function, and to define loops. Mutations were incorporated cumulatively into the protein sequence. Mutants were screened for tetramer formation, biotin dissociation, and reduced immunoreactivity with pooled patient sera. Patient antisera recognized one minor continuous epitope with binding locus at residue E101 and one major discontinuous epitope involving amino acid residues E51 and Y83. Mutation of residues E51, Y83, R53, and E116 reduced reactivity with patient sera to <10% that of streptavidin, but these mutations were no less antigenic in rabbits. Mutant 37, with 10 ami...Continue Reading

References

Mar 1, 1991·Molecular Immunology·J Novotny
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T Sano, C R Cantor
Mar 25, 1988·Science·M VerhoeyenG Winter
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C QueenT A Waldmann
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W A HendricksonR P Phizackerley
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S HustonR Crea
Jan 1, 1986·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·D A GoodwinJ P Leung
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·T Sano, C R Cantor
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·E T Zambidis, D W Scott
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·T SanoC R Cantor
Jun 1, 1997·Protein Science : a Publication of the Protein Society·S FreitagR E Stenkamp
Nov 14, 1997·Biochemistry and Molecular Biology International·N Subramanian, P R Adiga
May 6, 1998·Protein Science : a Publication of the Protein Society·V ChuP S Stayton
Sep 2, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·S K Vaswani, R G Hamilton
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·D B AxworthyA R Fritzberg

❮ Previous
Next ❯

Citations

Oct 1, 2008·Histochemistry and Cell Biology·Paul Debbage, Werner Jaschke
Mar 14, 2003·Drug Discovery Today·Shannon A MarshallJohn R Desjarlais
Jun 2, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maria C Palanca-WesselsOliver W Press
Jan 27, 2010·The Journal of Biological Chemistry·Antonio VerdolivaRita De Santis
Sep 25, 2010·Cancer Biotherapy & Radiopharmaceuticals·Fiorella PetronzelliRita De Santis
Jun 3, 2006·Nucleic Acids Research·Ted C ChuMatthew Levy
Aug 22, 2007·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Philip SavageRuth R French
Jul 24, 2012·Radiology·Moritz F Kircher, Jürgen K Willmann
Oct 6, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Nicole CauchonJohan E van Lier
Jan 25, 2011·Gastroenterology·Marybeth A Pysz, Jürgen K Willmann
Sep 27, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Qi YangSamuel K Lai
Dec 12, 2012·Protein Science : a Publication of the Protein Society·Kyohei YumuraAkira Sugiyama
Jul 16, 2009·Journal of Cellular and Molecular Medicine·Markus A MoosmeierFelix Hoppe-Seyler
Dec 2, 2014·Journal of Bioscience and Bioengineering·Tatsuya KawatoAkira Sugiyama
Mar 24, 2011·Bioconjugate Chemistry·Naohiro TakemotoHiroo Iwata
Mar 2, 2017·Advanced Healthcare Materials·Tobias FührmannMolly S Shoichet
Feb 1, 2007·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Philip SavageJulian Dyson
Feb 8, 2005·The Journal of Biological Chemistry·Henri R NordlundMarkku S Kulomaa
Oct 30, 2008·Journal of Immunotoxicology·Erwin L Roggen
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jürgen K WillmannSanjiv S Gambhir
Apr 20, 2002·Cancer Control : Journal of the Moffitt Cancer Center·Mitchell E ReffGary Braslawsky
Jun 22, 2013·Chemical Society Reviews·Juan GalloEric O Aboagye
Aug 16, 2016·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Brooks D LindseyPaul A Dayton
Sep 24, 2015·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Igor SpivakFabian Kiessling
Oct 2, 2020·Nanomaterials·Gurbet KöseFabian Kiessling
Jan 6, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lotfi Abou-ElkacemJürgen K Willmann
Feb 24, 2021·Bioconjugate Chemistry·Maxime AyerHarm-Anton Klok
Aug 6, 2019·ACS Applied Materials & Interfaces·Vincent Huynh, Ryan Gavin Wylie
Dec 6, 2018·ACS Nano·Weston J SmithDmitri Simberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.